1.
Alexandria Journal of Pharmaceutical Sciences. 1995; 9 (3): 225-227
em Inglês
| IMEMR
| ID: emr-36226
RESUMO
Novel alkylating analogs of phencyclidine [PCP] have been synthesized in the hope of targeting brain tumors. The compounds were designed to fulfill the skeletal requirements of PCP and those of nitrogen mustard analogs. Chemically, the new compounds would be considered as 1-arylcycloalkyl [bis [2-chloroethyl]] amines